EMA guideline on synthetic peptides (2026): what it means for the EU
Since 1 June 2026 a separate EMA guideline for synthetic peptides applies in the EU. What it covers, who it applies to and why RUO research peptides fall outside it.
Knowledge base
Knowledge base
Knowledge base
Peptides and anti-doping rules: the 2026 WADA Prohibited List explained
The 2026 WADA Prohibited List has applied since 1 January 2026. For research peptides, class S0 is decisive: any pharmacological substance without marketing authorisation is prohibited, and at all times. Semaglutide and tirzepatide are monitored, not prohibited. This article explains the classes, the 2026 changes and the most common misconceptions. Research Use Only.
Knowledge base
Peptides and wound healing: what the research shows
Diagram of the wound-healing phases (inflammation, proliferation, maturation) and the peptide targets under study — RUOInflammationProliferationMaturationThe phases of wound healing, schematically. Research
Knowledge base
Peptides and fatty liver (MASH): what the research shows
Update — 2026: survodutide-onderzoek bij MASH in fase 3 Het survodutide-onderzoek bij MASH heeft in 2026 een grote stap gezet.
Knowledge base
AI and the future of peptide design
Update 2026: AI-ontwerp toegepast op kankervaccins Het duidelijkste toepassingsgebied van AI-peptide-ontwerp in 2026 is het kankervaccin op maat. Een overzichtsartikel
Knowledge base
Peptides in cancer research: how researchers use them
Update 2026: AI en peptiden-kankeronderzoek komen samen In juli 2026 verscheen in Frontiers in Genetics een overzichtsartikel over kunstmatige intelligentie
Knowledge base
Peptides and recovery after stroke and brain injury: what the research shows
Diagram: from excitotoxicity and inflammation after brain injury to the studied peptide targets — RUOExcitotoxicityInflammationTargetspeptidesStudied targets, schematically. Research Use Only.
Knowledge base
The FDA and peptides: what is really going on (2026)
Update — 24 juli 2026: FDA-adviescommissie stemt over zeven peptiden BPC-157 en KPV — RUO-onderzoekspeptiden. Illustratief; geen therapeutische claim. Op
Knowledge base
Peptides and cardiac repair: how the research works (and what it does not yet prove)
Diagram of studied mechanisms of peptides in cardiac recovery: blood-vessel formation, less scar formation, mitochondrial protection — RUOBlood-vessel formationLess scarringMitochondrialprotectionStudied mechanisms, schematically. Research Use
Knowledge base
GLP-1 and the next generation: how the research works and what it shows
Update — ADA 2026: nieuwe GLP-1-data op een rij Op het ADA-congres van 2026 kwamen de eerste grote uitkomsten van